Thermo Fisher Scientific Receives CE Mark for its Diagnostic Test to Detect COVID-19 WALTHAM, Mass., March 26, 2020 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced that it has received the CE mark in the European Union for its diagnostic test to detect nucleic acid from SARS-CoV-2, the... Read more
EDEN PRAIRIE, Minn., March 25, 2020 /PRNewswire/ — MTS Systems Corporation (NASDAQ: MTSC), a leading global supplier of high-performance test systems, motion simulators and sensors, today announced it has been awarded the largest single order in its 54-year history, valued at over $70 million, to design, manufacture and install two of the world’s largest, and most... Read more
EDEN PRAIRIE, Minn., March 25, 2020 /PRNewswire/ — MTS Systems Corporation (NASDAQ: MTSC), a leading global supplier of high-performance test systems, motion simulators and sensors, today announced it has been awarded the largest single order in its 54-year history, valued at over $70 million, to design, manufacture and install two of the world’s largest, and most... Read more
Thermo Fisher Scientific Continues Investments to Accelerate Biopharma Commercialization Capabilities and capacity now available to help customers of all sizes meet increasing demand for new biologics, cell and gene therapies, and drug products NEEDHAM, Mass., March 23, 2020 /PRNewswire/ — For biopharma companies faced with increasing demand for new biologics, cell and gene therapies, and drug... Read more
Danaher Receives Clearance From U.S. Federal Trade Commission For The Acquisition Of The Biopharma Business Of General Electric Life Sciences WASHINGTON, March 19, 2020 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (“Danaher”) announced today that the U.S. Federal Trade Commission (the “FTC”) has accepted the proposed consent order in connection with Danaher’s definitive agreement with General... Read more
Hilden, Germany, and Germantown, Maryland, March 13, 2020 – QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced it will develop a new QIAstat-Dx test kit to differentiate the novel SARS-CoV-2 coronavirus from 21 other serious respiratory infections and will receive advanced development support from the U.S. Department of Health and Human Services’ Office of... Read more
First commercial test for SARS-CoV-2 will enable expedited coronavirus testing to meet urgent medical needs Testing on widely available, high-volume cobas 6800/8800 will significantly increase available testing capacity Roche expedites test development to support urgent need for patient testing during pandemic outbreak to avoid a further spread of the virus at an early stage of... Read more
Next-generation cytology test provides additional information for HPV-positive women who may have cervical pre-cancer More sensitive than Pap cytology testing when used as triage test for HPV-positive screening results, helping to improve the detection of cervical pre-cancer The first biomarker-based test specifically approved by the FDA to triage women with HPV-positive / Pap cytology-negative co-testing... Read more
Thermo Fisher Scientific Names Paul G. Parker to Head Strategy and Corporate Development WALTHAM, Mass., March 10, 2020 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that Paul G. Parker will join the company, effective April 15, 2020, as senior vice president, strategy and corporate development, which also... Read more